Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model

<p>Representative T1-weighted MR images of the DCN in normal rats and diabetic rats 42 days after the last injections of saline, gadodiamide, gadopentetate dimeglumine, and gadoterate meglumine. Increased signal intensities of the DCN are shown with white arrows.</p>

BioMed Research International

fig3

Figure 3

Figure 3: Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model 

Figure 3 | Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model 